Arkolith/Insider Trading/RPRX/Form 4

Coyne Terrance P.

EVP & CFORoyalty Pharma plc (RPRX) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)1K$46.67$60K46K
Mar 2, 2026Sell(S)10K$47.01$490K99K
Mar 2, 2026Sell(S)22K$46.67$1.0M109K
Mar 2, 2026Sell(S)583$47.01$27K46K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001814876-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML